Filing Details
- Accession Number:
- 0001209191-19-046934
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-21 11:37:44
- Reporting Period:
- 2019-08-16
- Accepted Time:
- 2019-08-21 11:37:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1667633 | Forty Seven Inc. | FTSV | Pharmaceutical Preparations (2834) | 474065674 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1743780 | H Chris Takimoto | C/O Forty Seven, Inc. 1490 O'Brien Drive, Suite A Menlo Park CA 94025 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-08-16 | 663 | $6.36 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan.
- Reflects shares acquired under the Forty Seven, Inc. 2018 Employee Stock Purchase Plan on August 15, 2019.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.47, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth this footnote.
Billionaire Hedge Funds
